Skip to main content

Table 3 Hematological and renal toxicity of treatment

From: Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

   All (n = 61) Valacyclovir (n = 15) Valganciclovir (n = 16) Foscarnet (n = 30) P
Change in parameter (post-treatment – pre-treatment), median (range)
  Creatinine (μM) 14 (−31 to 126) 2 (−31 to 57) −2.5 (−70 to 73) 31.6 (−65 to 126) 0.009
  ANC (x103/mm3) −0.05 (−20.6 to 5.0) 0.19 (−4.2 to 3) −1.5 (−7.5 to −1.1) 1.1 (−20.6 to 5.0) 0.012
  Platelet (x103/mm3) 6 (−123 to 196) 6 (−72 to 82) −7.5 (−123 to 196) 13 (−92 to 150) 0.335
  1. ANC, Absolute neutrophil count